Head and neck squamous cell carcinoma (HNSCC) is common worldwide and is associated with a poor rate of survival. Identification of new markers and therapeutic targets, and understanding the complex transformation process, will require a comprehensive description of genome expression, that can only be achieved by combining different methodologies. We report here the HNSCC transcriptome that was determined by exhaustive differential display (DD) analysis coupled with validation by different methods on the same patient samples. The resulting 820 nonredundant sequences were analysed by high throughput bioinformatics analysis. Human proteins were identified for 73% (596) of the DD sequences. A large proportion (>50%) of the remaining unassigned sequences match ESTs (expressed sequence tags) from human tumours. For the functionally annotated proteins, there is significant enrichment for relevant biological processes, including cell motility, protein biosynthesis, stress and immune responses, cell death, cell cycle, cell proliferation and/or maintenance and transport. Three of the novel proteins (TMEM16A, PHLDB2 and ARH-GAP21) were analysed further to show that they have the potential to be developed as therapeutic targets.
Introduction
Head and neck squamous cell carcinoma (HNSCC) is common worldwide and has a poor rate of survival. It is the fifth most frequent cancer in men, with an incidence of about 780 000 new cases per year in the world. There is a need for a better understanding of HNSCC, for the development of rational targeted interventions and to define new prognostic or diagnostic markers (Hasina and Lingen, 2004) . The need to comprehensively describe gene expression patterns has engendered the emergence of large-scale technologies. Comprehensive transcriptome analysis is widely applied in cancer research (Liotta and Petricoin, 2000; Liang and Pardee, 2003) . Various methodologies have been used and each one has its advantages and limitations (Stein and Liang, 2002; Ding and Cantor, 2004) . Combining different approaches is important for a complete description of cancer transcriptomes. We report here a large-scale analysis of HNSCC by differential display (DD) and compare it with macro-and micro-array (mA) studies on the same samples.
DD (Liang and Pardee, 1992 ) is a powerful, simple and widely used technology. It combines three common techniques: reverse transcription (RT), polymerase chain reaction (PCR), polyacrylamide gel electrophoresis, and detects differences in gene expression patterns between two or more samples. The strength of DD is its ability to identify novel genes, whereas a limitation is the frequency of false positives requiring time-consuming validation methods. mAs generate a large amount data quickly, and they have become a standard tool. They give numerical estimates of gene expression levels for hundreds to thousands of sequences spotted on various supports. However, the data obtained depend on the information that was used to generate the arrays, and there are problems of sensitivity, reproducibility and specificity for homologous sequences (Stein and Liang, 2002; Liang and Pardee, 2003) . As both DD and mAs have limitations, combining the two methodologies is expected to give a more comprehensive description of cancer transcriptomes.
Here, we report the first extensive description of hypopharyngeal carcinoma differential gene expression using large-scale DD combined with reverse Northern and macroarray blot (MAB) validation. We compared the results with a parallel Affymetrix mA study that used the same samples (Cromer et al., 2004) . In addition, innovative bioinformatics tools were used to analyse the results. We used our integrative genomics and bioinformatics platform Gscope and three-step protocol (Chalmel F, submitted) in order to assign computationally cross-validated human protein sequences to each DD nucleotide sequence. We evaluated the concordance between the gene expression profiles generated by the different technologies. The large sets of genes that were shown to be differentially expressed were functionally analysed, in order to describe biological relevant pathways. Several novel genes were evaluated phenotypically to describe their observable characteristics (such as localization and expression levels), and shown to be candidates for further evaluation as targets to develop therapeutics for cancer.
Results

PCR-DD and validation by reverse Northern hybridization
A pilot study was previously reported, that described 70 sequences obtained from a PCR-DD comparison of the transcriptomes of three stages of HNSCC and corresponding normal tissue (N) (Figure 1 ) (Lemaire et al., 2003) . Sequences from differentially displayed bands were selected and validated by reverse Northern hybridization (RNH) using 'mixed' probes, consisting of the particular combination of HAP primers used for the DD (Figure 1 ). As this approach selected few clones, we investigated different methods to prepare the probes, finally resorting to 'focused' probes prepared with each specific HAP primer, which improved the hybridization signals and thereby allowed us to select and validate a more comprehensive set of sequences. We now report a large-scale study, in which a total of 2467 clones were selected by RNH (choosing where possible two clones from each band), and sequenced ( Figure 1 ). The sequences were analysed by high throughput automatic analysis (see Materials and methods).
Of the 2467 sequences, 467 were immediately excluded for different reasons. A total of 30 sequences were nonhuman (bacteria, plasmids, etc.), 304 were not analysable because of their bad quality or the presence of repeats (i.e. ALUs, MIRs, L3, MER47A, etc.) and 133 were too short (less than 25 bases). The remaining 2000 sequences corresponded to 820 differentially expressed nonredundant (NR) genes. Most of the redundancy resulted from sequencing two or more clones from the same DD band. The DD conditions were sufficiently selective that particular transcripts were rarely represented by different bands. The final NR list contains 432 sequences that are overexpressed in tumours, 349 that are underexpressed, and 39 that have more complex profiles, including different profiles between tumour types.
MAB analysis with a larger number of patient samples In order to validate the analysis by a different approach, and to extend it to more patients, cDNAs were spotted on MABs. The MABs were hybridized in triplicate with 50 different labelled cDNAs, prepared from 30 tumours (T) and 20 matched N tissues. The hybridization signals were low (near background) for 77% of the spots, medium for 20% and high for 3%. The high proportion of low hybridization signals is expected, as low abundance transcripts constitute a large proportion of the overall mRNA population. Differentially expressed sequences were identified by statistical analysis of all of the signals (to minimize overlooking relevant Figure 1 Overviews outlining the DD protocol and the bioinformatics sequence analysis of the 2467 sequences. The pilot study has been reported (Lemaire et al., 2003) . sequences). A total of 163 clones showed different expression between T and N samples by the Student's ttest, 133 by the Wilcoxon signed rank test and 125 by significant analysis of microarrays (SAM) (Tusher et al., 2001) . In all, 97 clones were selected by all three tests, corresponding to 14 NR genes that were upregulated in tumours and 35 that were downregulated (Table 1;  Supplementary Table 1 and data not shown) .
T/N ratios of expression were calculated for the 347 spots with medium or high hybridization signals. These ratios were compared with the DD gel profiles for the samples analysed by both techniques (Figure 2a) . The MAB and DD profiles are similar for 64% of the clones. When low MAB ratios were excluded from the comparison, the correlation improved to 85% for ratios above 1.2, and finally attained 100% (Figure 2b) , showing that there is a good concordance between the two techniques. However, the low sensitivity of MABs restricts the comparison to only some of the DD sequences.
Comparison between the large-scale DD and Affymetrix mAs The patient samples used for the DD have also been analysed by Affymetrix HG-U95A mAs (Cromer et al., 2004) . We compared the expression profiles of sequences that were analysed by both approaches. Using Blast, we searched for the 820 NR DD sequences among the 12 448 target sequences (probe sets) on the mA. We obtained 331 significant matches, which represents more than one-third of the DD sequences. We excluded 52 genes that gave low signals on the mA (detection call was absent or marginal) and 11 that had a complex DD profile. We found a good correlation (68.7%, 184/268) between the DD and mA expression profiles (Figure 2c ). The correlation was not increased by choosing increasing cutoffs for the mA hybridization signal intensity (200, 650, 1000; 68.7, 68.1, 67.8%, respectively) . However, using cutoffs for the T/N mA-ratios, the correlation gradually increased to 100% (Figure 2d ). mAs ratios may only be significant if they are at least 2-to 3-fold (Draghici et al., 2003) . With cutoffs of 2 or 3, and a DD cutoff of 1, the correlations reached 83% (49/59) and 92% (33/36 genes), respectively.
Further analysis of three selected DD clones Three sequences from the DD analysis were chosen for further analysis because they had not been described in the literature at the time of their discovery and had characteristics that might be useful for therapeutic intervention, such as expression on the cell surface (TMEM16A) and links to pathways already used for drug discovery (PI3-kinase, PHLDB2; Rho-GTPases, ARHGAP21; see Discussion). They were analysed by quantitative RT-PCR (RT-QPCR) to reconfirm their expression pattern and to extend the analysis to more patients. They were also analysed by Northern blots to establish the size of the transcripts, and antibodies were developed to analyse expression at the protein level by immunohistochemistry (IHC). TMEM16A (Transmembrane protein 16A), a putative receptor (Katoh, 2003) , has been given various names FLJ10261 (Katoh, 2003) , TAOS2 (Tumour Amplified and Overexpressed Sequence 1) (Huang et al., 2002) , ORAOV2 (ORAl cancer OVerexpressed 2) (Strausberg et al., 2002) and DOG-1 (Discovered On GIST-1) (West et al., 2004) ). The three candidates were isolated from bands that were more intense in tumour lanes on the DD gels (Figure 3 , upper panels). In the DD overall, there was one series of bands for TMEM16A, three for PHLDB2 and two for ARHGAP21. One of the bands for ARHGAP21 (indicated by an asterisks) was shown by RNH to correspond to two differentially expressed sequences with opposite profiles. Using RT-QPCR with 63 hypopharyngeal tumours for which there were 42 matched N tissues (Figure 3a , upper middle panel), TMEM16A RNA was found to be overexpressed in a very high proportion of tumours (84%), with a large average 17-fold increase in the expression. On Northern blots, we detected the predicted major transcript migrating around 4.5 kb, which was more intense in the tumours samples from all four patients (lower middle panel). We produced antibodies against the protein (Materials and methods) and used them for IHC. TMEM16A was detected distinctly in the cytoplasm of neoplastic cells of HNSCC tumours, and diffusely in the basal layer of the epithelium of N tissue (uvula). These antibodies stained GIST samples strongly and homogeneously (data not shown), in agreement with a recent report (West et al., 2004) .
PHLDB2 codes for a 160 kDa protein with a unique spectrin repeat and a C-terminal Pleckstrin homology domain (Paranavitane et al., 2003) . Using RT-QPCR, we found that PHLDB2 is overexpressed in 10/12 HNSCC (six-fold on average, Figure 3b ). On Northern blots, we detected a predominant band migrating around 6 kb that is more intense in four of the tumours compared to normal. There was no detectable signal in tumour and normal RNA from another patient. By IHC with antibodies developed against the central part of PHLDB2 (amino-acids 642-660), we detected cytoplasmic staining that was specific for the neoplastic component of tumours, whereas there was no detectable staining in normal uvula epithelium.
ARHGAP21 (previously called ARHGAP10 (see Genecards, http://www.genecards.org)) maps to chromosome 10p12.32 and codes for a member of the Rho-GAP family (Basseres et al., 2002) , By RT-QPCR in a panel of 23 hypopharyngeal carcinomas and their matched N tissues (Figure 3c ), we found higher levels in most tumour samples (91%) compared to the N tissue samples, with increasing in range from 1.5-to 5-fold (average 2.4). Using Northern blots, a major band was detected migrating around 7.5 kb. Differences in band intensity could not be reliably deduced from the Northern blots because of the weak signals. By IHC, using an antibody against a central part of the protein (amino-acids 383-400), we clearly detected weak cytoplasmic staining in the neoplastic cells of the tumour, and no detectable staining of the epithelium from normal uvula (Figure 3c ). These results, obtained for three genes that were not cross-verified on MAB or mA, further confirm the DD analysis and the relevance of this approach. They suggest that most of the transcripts that are overexpressed in tumours are derived from the neoplastic component, as expected from the high proportion (>70%) of transformed cells in the tumours used for the DD analysis.
Bioinformatics analysis of the sequences identified by DD
The 820 NR sequences were analysed by high throughput bioinformatics. Complications associated with the analysis included unambiguous assignment to complete transcripts (due to their location in the 3 0 -untranslated regions of transcripts), and elimination of redundancy (Broude, 2002) . We used Gscope, our integrative genomics and bioinformatics platform, and applied our three-step protocol (Chalmel F, submitted) , in order to assign a computationally cross-validated human protein sequence (see Materials and methods) to each DD nucleotide sequence. We identified a human protein for 73% (596/820) of the DD sequences, of which 532 (89%) were annotated and 64 did not have any GO, KEGG or domain annotations (Supplementary Table 1 ). The majority (36/64) of the We analysed the 596 differentially expressed sequences corresponding to cross-validated proteins by computational functional analysis, using the program GOAnno that searches for GO annotation enrichment compared to the whole human proteome (GOAnno; Chalmel et al., 2005) . We obtained eight main enrichments in biological processes (Table 2) , including cell motility, protein biosynthesis, response to stress, immune response, cell death, cell cycle, cell proliferation and/or maintenance, and transport. The same biological processes were enriched in the mA analysis (Cromer et al., 2004; and data not shown) . These are all important biological processes that are known to be involved in tumorigenesis. Interestingly, there were also strong enrichments for the response to stress for sequences that overlapped between the DD and either the MABs (45 sequences) or the mAs (59 sequences), (5/45, Z-score ¼ 5.5 and 8/59 Z-score ¼ 7, respectively).
Discussion
Methods and strategy
We report here the first exhaustive hypopharyngeal carcinoma differential gene expression analysis, involving an extensive DD analysis, coupled with RNH validation with focused probes and revalidation with MAB and Affymetrix mAs, using the same samples. The first step was a large scale analysis by DD that theoretically covers 90% of expressed sequences (three 3 0 primers (HT11A/G/C) and 58 5 0 primers (HAP1-10, 33-80, (Liang, 1998) ). All the clones were selected for differential expression between pools of T and N samples by RNH. This procedure allowed us to eliminate parasite sequences that comigrate during DD electrophoresis, and the use of 'focused' probes improved the sensitivity, with higher hybridization levels than linear probes (Trenkle et al., 1999) . The collection of 820 NR sequences that are differentially expressed between tumour and normal samples is a high quality and unique description of the HNSCC transcriptome. There are various advantages of using PCR-DD compared to DNA arrays (Broude, 2002; Liang, 2002) .
PCR-DD maximizes the detection of 'novel' sequences. We found 248 NR sequences that apparently do not correspond to known proteins, and about half of them do not match ESTs. Moreover, we found that roughly half of these 'unknown genes' (131/266) are not represented on the latest version of Human Affymetrix Figure 3 Analysis of TMEM16A (a), PHLDB2 (b) and ARHGAP21 (c). Top panels: DD profiles. The overall DD differential expression value was estimated from the relative differences in intensity of the bands for each sample. In the DD overall, there was one series of bands for TMEM16A, three for PHLDB2 and two for ARHGAP21. The asterisks indicates a case where more than one differentially expressed sequence comigrating in the band was identified by RN and independently validated by virtual Northern (data not shown). Second row of panels: RT-QPCR values are calculated in relative units adjusted to the RPLP0 (Ribosomal protein, large P0) internal control and to median values of normal samples. The mean values7standard deviations are indicated on the graph. Statistical analysis between T and N samples was carried out by Student's t-statistical tests. Third row of panels: Northern blots, the bars indicate tumour (T), invaded node (L) and normal (N) samples from the same patients. Top: specific probe, bottom: RPLP0 loading controls. Bottom panels: immunohistochemical staining of T and N samples. Arrowheads indicate cells stained with the specific antibodies.
mA (HG-U133_Plus_2_target downloaded at http:// www.affymetrix.com). Another strength of the DD approach is that it picks up genes that are not analysable by arrays, either because they are expressed at low levels or are not represented. Our PCR-DD analysis identified transcripts that could not be analysed with MABs and mAs. Only between 25% (347 clones) and 32% (3962 probes sets) gave high-quality hybridization signals with MABs or mAs, respectively. However, the good correlation (up to 100% with appropriate cut-offs) between the differential expression profile obtained by the DD protocol and these high throughput technologies confirms that our procedure has a high specificity. It is worth noting that there are 331 significant matches between our DD-selected sequences and the Affymetrix probes sets. This overlap represents more than one-third of the DD sequences, which is comparable to the 12 448 mA sequences representing more than one-third of the estimated human transcriptome (IHGSC, 2004) . There are other studies combining DD with array analysis that have experienced the same lack of sensitivity of arrays. Martin and collaborators (Martin et al., 2001) found that less than 10% (12/170) of the DD-isolated sequences spotted on a membrane gave useful results upon further analysis of additional patient samples. Several studies using PCR-DD and mAs as complementary approaches detected few genes (0-10) by both approaches (Outinen et al., 1998; Wells, 1999; Cirelli and Tononi, 2000; Oetting, 2000; Heilig and Sommer, 2004; Pascal et al., 2005) . Our large-scale study permits a more extensive comparison of PCR-DD and arrays, and shows that the correlation is good if certain reasonable selection criteria are used.
Genes and processes
Our study provides a list of genes differentially expressed between normal and cancer cells, among which the targets of oncogenesis and potential therapeutic targets need to be identified. The gene ontology analysis indicates that there are enrichments for increased metabolism, cell density and stress-associated genes, raising the possibility that they are secondary to the key events associated with oncogenesis. However, some of the stress-associated genes that we found are already validated targets, such as heat shock proteins.
The stress response may be required for cells to tolerate the genetic disarray characteristic of malignant transformation (Whitesell et al., 2003) . Some of the stressassociated genes are also involved in biological processes such as regulation of cell cycle (GO:0000074), antiapoptosis (GO:0006916) and activation of MAPK (GO:0000187). Among the genes involved in metabolism, the thioredoxin-related transmembrane protein (TXNDC) is overexpressed in tumours. It belongs to the thioredoxin-thioredoxin reductase system known to be involved in oncogenesis and tumorogenesis and to be a potential target for anticancer therapy for a wide range of human tumours (Lincoln et al., 2003) . Further phenotypic and functional analysis is required to define the most promising therapeutic targets.
We chose three genes (TMEM16A, PHLDB2 and ARHGAP21) for further analysis using complementary approaches on a larger number of patient samples. We confirmed that they are overexpressed in HNSCC compared to N tissue by quantitative RT-PCR, determined the size of the transcripts by Northern blotting and showed that the proteins are expressed in tumour cells by immunohistochemitry (see Results). The TMEM16A gene is located in the CCND1-EMS1 region (11q13), a locus that is frequently amplified in HNSCC (Muller et al., 1997) and is enriched in genes that are differentially expressed in hypopharynx carcinoma (Cromer et al., 2004) . TMEM16A is predicted to be associated with the cell membrane. PHLDB2 is a 160 kDa protein that has, in particular, a C-terminal Pleckstrin homology domain that binds phosphatidylinositol (3,4,5)-triphosphates (Dowler et al., 2000; Paranavitane et al., 2003) . The overexpressed sequence we detected lacks exon 25 (data not shown). The PHLDB2 gene is located in the 3q13 locus, which is frequently amplified in nasopharyngeal cancer (Huang and Yao, 2004) . Therapeutic strategies are being evaluated for the PI3 kinase pathway (Dancey, 2004) , raising the possibility that PHLDB2's PH domain might be a good candidate for targeted strategy development. ARH-GAP21 is widely expressed and codes for a Rho-GAP family protein (Basseres et al., 2002) . The ARHGAP21 gene is highly expressed in the muscle and brain, which are highly differentiated tissues, in agreement with the hypothesis that ARHGAP21 is important for cell differentiation (Basseres et al., 2002) . A bioinformatics analysis has identified two isoforms that are produced by alternative splicing of the human ARHGAP21 gene (Katoh, 2004) . We detected several splice variants (lacking exon 8, or both 7 and 8) in tumour RNA (data not shown), which could be important for tumorigenesis. Modulation of Rho GTPase activity by ARH-GAP21 may be a target for therapeutic intervention. However, it should be stressed that other criteria could have been used to select genes for further study, such as: biological process, number of bands, high level of hybridization in MAB, chromosomal localization and selection through both DD and another method. We identified in our pilot study two regions of the genome that are enriched for differentially expressed genes, 1q21 and 12p12-13 (Lemaire et al., 2003) . This enrichment is maintained in this study, in terms of both density (1q21 (13 genes) and 12p12-13 (25 genes)) and normalized relative density (1q21 (173.6) and 12p12-13 (165.6); see Cromer et al., 2004) . The same regions were identified in the Affymetrix mA study (Cromer et al., 2004) .
In summary, the present study reports a unique largescale description of genes differentially expressed between hypopharynx carcinoma tissues and N tissues. It provides a different perspective of the cancer transcriptome and highlights potential limitations of current methods used to describe tumour transcriptomes. We also report the phenotypic validation of three novel genes with potential to be developed as therapeutic targets.
Materials and methods
Tissue samples and RNA extraction All tumour samples and corresponding histologically N tissue were obtained, with informed consent, from 98 patients undergoing surgery for hypopharyngeal tumour resection. None of the patients presented distant metastasis, and surgery was the primary treatment. The set of samples common to DD and mA consisted of four entities including seven patients. One pool consisted of normal tissue (N) and three pools consisted of three categories of tumour tissue (T): early stage (E), no metastatic propensity (NM), with metastatic propensity (M) (Lemaire et al., 2003; Cromer et al., 2004) . Complementary sample sets with the same histological characteristics (hypopharyngeal tumour and corresponding normal tissue) were used for MAB (30T: 9E, 10NM, 11M and 20N), Northern blot or RT-PCR validation. Total RNA was extracted by the RNAeasy procedure (QIAGEN).
PCR-differential display
The PCR-DD protocol was performed as described previously (Lemaire et al., 2003) following original methods (Liang and Pardee, 1992; Liang, 1998) .
Macroarray blots
Production of the cDNA array MAB were prepared by spotting double dots of cDNAs onto positively charged nylon membranes (Amersham). The 1536 cDNAs were spread over two different nylon membranes. There were 1432 clones from DD corresponding to 664 NR genes, and 104 control probes corresponding to 10 ubiquitous genes and empty plasmid.
Cloned DD fragments were amplified by PCR using pGEM primers (M13f and M13r), purified by ethanol purification in 96-well plates and checked on agarose gels. PCR products (3 ng) were spotted onto nylon membrane using a Q-Pit spotter (Genetix) and crosslinked to the nylon surface by UV irradiation.
Probes preparation Total RNA from 50 selected samples (30 tumours and 20 matched normal tissues) was extracted according to the RNeasy procedure (QIAGEN). cDNAs probes for each RNA were prepared in triplicate by reverse transcription, amplification by T7 PCR and purification by ethanol precipitation.
Hybridization, detection and analysis Membranes were prehybridized for 4 h in hybridization buffer at 421C before adding [alpha 33 P]-dCTP-labelled probes (10 6 cpm, Megaprime random priming kit, Amersham). The membranes were hybridized overnight at 421C, washed in 2 Â SCC/0.1% SDS following by 0.1 Â SCC/0.1% SDS at 421C, and dried at room temperature. Membranes were exposed to phosphorimaging screens for 48 h. The screens were scanned with a Typhoon 8600 scanner (Amersham). The acquired images were analysed and the signal intensities quantified using the Image Quant software (Amersham). The triplicates were normalized by the quantile-quantile normalization method (Bolstad et al., 2003) and then in each separate experiment the data were normalized according to the median values. To avoid overlooking significant differentially expressed clone, all measured signals were considered for statistical analysis. The clones have been attributed a fold change T versus N and were identified as statistically differentially expressed by three types of analysis. Student's t-test was performed on log values and Wilcoxon' signed rank test on intensity value ranks. Student's t-test and Wilcoxon's signed rank test were performed separately on the duplicated spot of each clone and independently on the three experiments. Each significant analysis (Po0.05) was scored 1. A differential expression score was calculated for each clone as the sum of the scores. All the clones having a score higher than 3 were selected as statistically differentially expressed. The third analysis using SAM software (Significance Analysis of Microarray) (Tusher et al., 2001) was performed on the three hybridization experiments mean values.
DD sequence analysis
First of all, the DD sequences were searched for the presence of eukaryotic repeats using RepeatMasker (Smit, 1999 ) and a genome-based masking protocol (Katsanis et al., 2002) . Sequences less than 25 nucleotides long that could not be used were put aside. Blast searches (Altschul et al., 1997) against human sequence databanks (Genbank, Protall, Human ESTs, Human genome) were conducted using a percent identity cutoff of 95% and a match length cutoff equal to 50% of the query length. When the homologous sequence were obvious contaminants (Escherichia coli, Fusobacterium nucleatum, cloning vector), the DD sequences were removed from the analysis. Redundancy was removed at four levels: identical DD nucleotide sequences, overlapping locations on the human genome, the same protein accession numbers and the proteins sharing more than 95% of identity using Blast. The longest sequence was used to represent each cluster of redundant sequences. Proteins were considered hypothetical if their description included: 'hypothetical', 'predicted', 'similar to', 'KIAA', 'DKFZp', 'FLJ', 'putative'.
DD-mA comparison and analysis
Using Blast N, the nucleotide sequences from the DD protocol or their corresponding validated mRNA sequences were compared to the Blast database that we built with the Affymetrix HG-U95A target sequences (the target sequences are the sequences from which probes were selected; they were downloaded from http://www.affymetrix.com). The parameters for finding true homologues in the Blast outputs were as follows: for the mRNA against the mA target sequence an identity cutoff of 95% and a match length cutoff equal to 50% of the subject length, and for the DD clone sequence against the mA target sequence 90% identity and 50% of the query length. When several mA target sequences fulfilled these parameters, only the one having the best identity percent was kept, so that one mA sequence was assigned to one DD sequence. The mA target sequences having no detectable values (Absolute Call equal to Absent or Marginal) on the mAs in all the samples were excluded, leaving the list of analysable genes.
Correlation between DD and mA or MAB profiles Within the context of DD protocol, the difference of expression between T and N samples was quantified by subtracting the average intensities of the T from the N bands seen on the DD gels and coded on a scale of 0-3. Positive values indicate overexpression in T, negative underexpression in T, and zero difference between the averages complex. Complex expression profile clones were excluded from the DD-MAB or mA comparison. When the DD sequence had twin sequences, all the expression profiles were taken into account to calculate a consensus difference by subtracting the sums of the averages of the T from the N samples. For the mAs and the MABs, the T versus N fold change (FC) was calculated by dividing the average of the intensities of the T samples by the average of the N intensity values. If the ratio was more than 1, the expression profile was overexpressed in T, otherwise it was underexpressed in T and in this case the fold change was given a value of À(N/T) for ease of comparison with (T/N). The DD-mA (or DD-MAB) correlation ratio was calculated by dividing the number of analysable genes having the same expression profile in DD and mA (or MAB) by the total number of analysable genes.
Real-time quantitative PCR
Reverse transcription was performed with 1 mg total RNA, random primers and the Superscript II PCR system (Life Technologies). Q-PCR reactions were performed using the Light Cycler (Roche Diagnostics, Meylan, France) with the LC Fast start DNA master SYBR green I reaction mixture according to the manufacturer's instructions. In all, 2 ml of 1:100 diluted RT products were used in 20 ml reaction volume. The primers were chosen with the Primer3 software and their specificity was verified by Blast analysis on the NR database (nonredundant set of GenBank, EMBL, and DDJB databases). The primer sequences were: TMEM16A, 5 0 -CTCC TGGACGAGGTGGTATGG-3 0 and 5 0 -GAACGCCACGTA AAAGATGG-3 0 ; PHLDB2, 5 0 -CCTGTTGGATGTTGAAA GCA-3 0 and 5 0 -GAGCCTGCTGAACAATGTGA-3 0 ; ARHG AP21, 5 0 -AGTGATGCTGCCAAGGAAGG-3 0 and 5 0 -GAA TGACCCCGAAGGACAAC-3 0 ; the ubiquitous gene RPLP0, 5 0 -GAAGGCTGTGGTGCTGATGG-3 0 and 5 0 -CCGGATA TGAGGCAGCAGTT-3 0 . For each gene, a standard curve was constructed using serial dilutions of standard cDNAs (equivalent to 100, 40, 20, 10, 4, 2 and 1 ng of total RNA) derived from a pool of 10 hypopharyngeal tumours. The concentrations of primers, MgCl 2 , probes and cDNA were optimized to obtain linear standard curves. Unknown samples were estimated relative to these standard curves. PCR reactions were run at least twice for each sample. The median value was retained whenever the standard deviation did not exceed 15%. The mean of the N samples was given an arbitrary unit of 1. All values were normalized using ribosomal phospho-protein P0 (RPLP0) as an internal control. RPLP0 (originally called 36B4) is a ubiquitously expressed gene that has been routinely used in different laboratories as an internal control to normalize for the amount of RNA. In a large study (98 cases), we confirmed by real-time quantitative PCR (RT-QPCR) that its expression level remains relatively constant between HNSCC tumours and matched normal tissues (data not shown). RPLP0 gave better results than the commonly used control GAPDH, which was more variable between samples in our experiments. Statistical analysis between tumour and normal sample populations were carried out by statistical Student's t-test.
Northern blot
Total RNA was extracted from tissue samples with Trizol (Life Technologies, Cergy Pontoise, France). A measure of 20 mg of RNA was subjected to agarose 6% formaldehyde gel electrophoresis, and then transferred to Hybond N membranes (Amersham). [ 32 P]-labelled probes were generated with the Rediprime system (Amersham). Membranes were prehybridized and hybridized in 50% formamide at 421C according to the manufacturer's specifications, washed to a stringency of 0.1 Â SSPE/0.1% SDS at 501C and exposed to X-ray film (Kodak, Les Ulis, France) or to PhosphorImager screen and analysed using the typhoon ImageQuant software. Membranes were also probed with RPLP0 as a loading control. T, N and involved lymph node (L) samples from the same patients are present on the blot when available. The level of expression in tumour samples was analysed in comparison with the matched normal tissues after correction for loading.
Immunohistochemistry
Polyclonal antibodies were raised by injecting synthetic peptides to rabbits. Peptide EKERQKDEPPCNHHNTC located in the C-terminus of the putative protein derived from the coding sequence of TMEM16A gene -peptide QPQSKEHFRSLEERKKQHKC that corresponds to PHL DB2 amino-acid sequence from 642 to 660. The ARHGAP21 antibody was raised against a peptide corresponding to amino acids 383-400 (IDWKNYKTYKEYIDNRRL) of the protein. The antibodies were tested by Western blotting of transfected proteins expressed in COS or HeLa cells. Their specificities were verified by: comparison of transfected and nontransfected cells, peptide competition, comparison with preimmune serum and size comparison with flagged proteins detected with antiflag antibodies. In addition, the anti-TMEM16A and anti-ARHGAP21 antibodies detected endogenous proteins of the expected size in FaDu and HaCat cells, respectively (data not shown). Sections of patient samples were immunostained as previously described. Briefly, paraffin sections (3 mm.) were cut, floated on Superfrost-coated glass microscope slides and dried overnight at 371C. Sections were de-waxed with xylene and hydrated from ethanol to deionized water. Endogenous peroxidase activity was blocked by a 20-min incubation in 3% hydrogen peroxide. Antigen retrieval was performed by pressure cooking for 3 min in 0.1 M citrate buffer pH 6.0 (TMEM16A), by 15 min incubation in pressure cooker (microwave tender cooker, Biogenex) in 0.1 M citrate buffer pH 6.0 (PHLDB2) or at 901C for 10 min in 0.01 M citrate buffer (ARHGAP21) and then 20 min cooling. Slides were blocked using the BSA for 30 min at room temperature (PHLDB2). Excess blocking solution was removed, the primary antibody (rabbit polyclonal anti-B14 1/500, anti-PHLDB2 1/1500 dilution, and anti-ARHGAP21 1/100) was added with overnight incubation at 41C. Preimmune rabbit IgG were used as a negative control on serial sections (data not shown). The slides were rinsed for three 5-min cycles in TBS. Incubation with secondary antibody was carried out at 371C for 60 min. All slides were then rinsed three times in TBS. DAB kit (Vector Laboratories) was used for revelation and allowed to develop for 2-10 min. The slides were then rinsed with TBS and counterstained with haematoxylin for 1 min, then mounted.
